413
Views
3
CrossRef citations to date
0
Altmetric
Review

Poly(Caprolactone Fumarate) and Oligo[Poly(Ethylene Glycol) Fumarate]: Two Decades of Exploration in Biomedical Applications

, , , &
Pages 319-356 | Received 05 Jan 2020, Accepted 12 Apr 2020, Published online: 04 May 2020
 

Abstract

The past few decades have seen a significant interest in the fumarate-based polymers for biomedical applications. Poly(caprolactone fumarate) (PCLF) and oligo[poly(ethylene glycol) fumarate] (OPF) are derivatives of polycaprolactone and polyethylene glycol respectively, which are rendered cross-linkable, biodegradable, and possess tunable mechanical properties by the introduction of unsaturated fumarate groups. PCLF is a hydrophobic polymer, mostly applied as pre-formed or 3-D printed scaffolds while OPF is an aqueous-solvent based polymer mostly explored as a hydrogel system in tissue regeneration and drug delivery applications. This review summarizes the synthesis methods of these two polymers and the improvements on these methods over the years. The influence of precursor monomers on the physical properties of the synthesized polymer is comprehensively described, along with the cross-linking strategies. The major focus of this review is to highlight the applications of PCLF and OPF over the years in nerve, cartilage, and bone tissue engineering, as well as drug delivery applications. The nano- and micro- composites developed using these polymers to better accommodate the required application especially in cartilage and bone tissue regeneration are explained in detail. Finally, we provide our perspective on future directions for these polymers in regenerative medicine.

Additional information

Funding

This work was supported by National Institutes of Health under grant number R01 AR075037.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.